IBEX 35
11.095,20 -23,70 (-0,21%) Euro Stoxx 50
4.933,77 -2,20 (-0,04%) Dólar/Euro
1,0688 -0,0027 (-0,26%) Petróleo Brent
85,73 +0,72 (+0,85%) Oro
2.320,90 -9,90 (-0,42%) Bitcoin EUR
57.296,96 -29,14 (-0,05%)
Broncus Holding Corporation (2216.HK)
Broncus Holding Corporation
Building 8
Room 801, 8/F No. 88 Jiangling Road, Xixing Street Binjiang District
Hangzhou
China
86 571 8659 5016
https://www.broncus.com
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 308
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Hong Xu | Chairman of the Board & CEO | 1,32M | N/A | 1987 |
| Thomas M. Keast | VP, Operation Director & Scientist in resident | N/A | N/A | N/A |
| Feng Yao | Sr. Accountant | N/A | N/A | N/A |
| Ms. Elaine Lu | Director of Finance & Administration | N/A | N/A | N/A |
| Ms. Yin Kwan Ho | Company Secretary | N/A | N/A | 1978 |
Descripción
Broncus Holding Corporation, a medical device company, focuses on the development of interventional pulmonology products in Mainland China, the European Union, the United States, and internationally. The company offers InterVapor, a thermal vapor treatment system to treat chronic obstructive pulmonary disease (COPD); RF-II, transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation (TLD) Ablation System for the treatment of COPD; H-Marker, treatment for lung cancer/lung nodules; disposable nebulizing micro-catheter for endoscope used for accurate anti-inflammation, local hemostasis, phlegm reduction and elimination, staining location, and local anesthesia; and BroncTru, a disposable transbronchoscopic puncture dilatation catheter. It also provides navigation products, such as LungPoint Virtual Bronchoscopic Navigation, a computer-assisted image-based navigation software system; LungPoint Plus/Archimedes Lite, a system that provides real-time navigation within the airways for lung biopsy and other procedures; and LungPoint ATV System, an archimedes system. In addition, the company offers diagnosis products, such as FleXNeedle, a multipurpose biopsy needle; Archimedes Sheath, a sterile single-use flexible tube that provides a working channel during a bronchoscopic procedure; Archimedes Dilation Balloon, a sterile single-use flexible tube with a balloon at or near the distal tip that is inserted through the bronchoscope or sheath and used to dilate the target lung tissue of the bronchial tree; and BioStarNeedle, ATV FleXNeedle CN, ATV Sheath, ATV Balloon, and Steerable Sheath. The company was incorporated in 2012 and is headquartered in Hangzhou, China.
Gobierno corporativo
El ISS Governance QualityScore de Broncus Holding Corporation, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
